LAS VEGAS, NV–(Marketwired – August 05, 2016) – CV Sciences, Inc. (OTCBB: CVSI), is pleased to announce the latest addition to its consumer products division, Purified Liquids™, which offers the highest quality, premium CBD vape e-liquids available on the market today. The launch of this brand targets the booming vape industry, which is expected to reach US$32.11 billion worldwide by 2021, according to Research and Markets Assessment of the World Vape Market.
“Over the last 2 years, we observed the vape industry blossom into the powerhouse that it is today,” stated Michael J. Mona, III, co-founder and chief operating officer at CV Sciences. “As the leader in hemp-derived CBD oil, our unwavering commitment to excellence resulted in over a year of research and development by our in-house laboratory team. In the end, we created a product line of consistently pure, safe, and solvent-free CBD vape e-liquids of which we are very proud.”
Made from 99.9% CBD from hemp-derived crystals and containing 0% THC, each Purified Liquids™ product provides at least 360mg of hemp-derived CBD per 30mL bottle, offering 12mg of CBD per mL.
Purified Liquids™ is proud to introduce the first two delicious CBD vape flavors:
  • Inertia: Guava Honeydew with tangy, fruit-forward, and tropical notes
  • Isotope: Watermelon Chill with a refreshing, sweet, clean taste and hints of spearmint

The bottles containing Purified Liquids™ were specially designed to block UV light. By blocking UV light, the CBD vape liquids are protected against oxidation and separation, leaving a great tasting product every time.
Using a proprietary process in CV Sciences’ state-of-the-art GMP laboratory, Purified Liquids’™ solvent-free solutions are unique from other CBD vape products. CBD crystals are derived from 100% agricultural hemp as opposed to synthetic chemicals or compounds. Each product is thoroughly lab tested to ensure the absence of harmful chemicals, heavy metals, solvents, or pesticides. Third party certificates of analysis are available upon request.
Purified Liquids™ are available for sale online and for wholesale distribution.
ABOUT CV SCIENCES: CV Sciences, Inc. (OTCBB: CVSI), formerly CannaVest Corp., located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and is engaged in the development, marketing and sale of end consumer products containing CBD, which is refined into its PlusCBD Oil™ and Purified Liquids™ brands. Learn more about Purified Liquids™ at PurifiedLiquids.com.

For more information about CV Sciences, Inc. or Purified Liquids™, please contact:
Alex Huber
alex.huber@cvsciences.com

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less